| Literature DB >> 24460727 |
Cecilia Bergström1, Margareta Persson, Ingrid Mogren.
Abstract
BACKGROUND: Pelvic girdle pain (PGP) in pregnancy is distinct from pregnancy-related low back pain (PLBP). However, women with combined PLBP and PGP report more serious consequences in terms of health and function. PGP has been estimated to affect about half of pregnant women, where 25% experience serious pain and 8% experience severe disability. To date there are relatively few studies regarding persistent PLBP/PGP postpartum of more than 3 months, thus the main objective was to identify the prevalence of persistent PLBP and PGP as well as the differences over time in regard to pain status, self-rated health (SRH) and family situation at 12 months postpartum.Entities:
Mesh:
Year: 2014 PMID: 24460727 PMCID: PMC3937130 DOI: 10.1186/1471-2393-14-48
Source DB: PubMed Journal: BMC Pregnancy Childbirth ISSN: 1471-2393 Impact factor: 3.007
Figure 1Selection chart of the study group.
Descriptive information of the study group at Q3
| 31.56 (4.9) | 32.2 (4.6) | 31.3 (5.7) | 31.9 (4.8) | |
| 26.2 (3.7) | 25.8 (4.3) | 24.7 (3.7) | 25.7 (4.1) | |
| Single | - | 3 (2.6) | 2 (7.4) | 5 (2.8) |
| Cohabiting | 24 (70.6) | 71 (61.7) | 12 (44.4) | 107 (60.8) |
| Relationship but not cohabiting | - | 1 (0.9) | 1 (3.7) | 2 (1.1) |
| Married | 10 (29.4) | 40 (34.8) | 12 (44.4) | 62 (35.2) |
| Compulsory school | 2 (5.9) | 3 (2.6) | 1 (3.7) | 6 (3.4) |
| High school | 13 (38.2) | 53 (46.1) | 16 (59.3) | 82 (46.6) |
| Folk high school | - | 2 (1.7) | - | 2 (1.1) |
| University | 19 (55.9) | 57 (49.6) | 10 (37.0) | 86 (48.9) |
| 1 | 16 (91.2) | 37 (32.2) | 12 (44.4) | 65 (36.9) |
| 2 | 9 (26.5) | 48 (41.7) | 10 (37.0) | 67 (38.1) |
| 3 | 8 (23.5) | 24 (20.9) | 3 (11.1) | 35 (19.9) |
| ≥4 | 1 (2.9) | 6 (5.2) | 2 (7.4) | 9 (5.1) |
| Yes | 19 (55.9) | 69 (60) | 19 (70.4) | 107 (60.8) |
| No | 15 (44.1) | 46 (40) | 8 (29.6) | 69 (39.2) |
| Very good | 7 (20.6) | 18 (15.7) | 2 (7.4) | 27 (15.4) |
| Quite good | 18 (52.9) | 56 (48.7) | 10 (37.0) | 84 (48.0) |
| Fair | 6 (17.6) | 34 (29.6) | 10 (37.0) | 50 (28.6) |
| Quite poor | 3 (8.8) | 5 (4.3) | 4 (14.8) | 12 (6.9) |
| Poor | - | 1 (0.9) | 1 (3.7) | 2 (1.1) |
| Yes | 3 (8.8) | 7 (6.1) | 6 (22.2) | 16 (9.1) |
| No | 31 (91.2) | 107 (93.0) | 21 (77.8) | 159 (90.3) |
| Snuff | - | 1 (0.9) | - | 1 (0.6) |
Numbers in parenthesis are percentage unless otherwise specified.
1‘No pain’ denotes respondents reporting remission of LBP/PGP at Q3.
2‘Recurrent pain’ denotes respondents reporting recurrent LBP/PGP at approximately 14 months post-partum at Q3.
3‘Continuous pain’ denotes respondents reporting continuous LBP/PGP at approximately 14 months post-partum at Q3.
Figure 2Character of pain at Q2 (a) and Q3 (b).
Descriptive information of the study group at Q3 regarding previous LBP, and pain site localisation as reported at Q1
| | ||||||
|---|---|---|---|---|---|---|
| | | | 0.030* | 0.024* | 0.482 | |
| Yes | 10 (30.3) | 59 (51.8) | 16 (59.3) | | | |
| No | 23 (69.7) | 55 (48.2) | 11 (40.7) | | | |
| | | | 0.112 | 0.256 | 0.984 | |
| Back | 10 (29.4) | 21 (18.3) | 5 (18.5) | | | |
| Front | 4 (11.8) | 6 (5.2) | 1 (3.7) | | | |
| Mixed (back and front) | 20 (58.8) | 88 (76.5) | 21 (77.8) | |||
Test for difference between groups (Pearson’s chi-square).
1‘No pain’ denotes respondents reporting remission of LBP/PGP at Q3.
2‘Recurrent pain’ denotes respondents reporting recurrent LBP/PGP at approximately 14 months after pregnancy at Q3.
3‘Continuous pain’ denotes respondents reporting continuous LBP/PGP at approximately 14 months after pregnancy at Q3.
*Significance test p<0.05.
Comparing highest level of pain at Q1, Q2 and Q3 using women with ‘no pain’ at Q3 as the reference group
| | | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q1: During pregnancy | 111 | 6.3 | 2.5 | 0.711 | 27 | 7.8 | 2.9 | 0.008* | 0.007** |
| Q2: During the past 6 months | 114 | 6.0 | 3.5 | 0.058 | 27 | 8.3 | 2.7 | <0.001* | <0.001** |
| Q2: Past week | 114 | 4.1 | 4.1 | 0.333 | 27 | 7.1 | 4.8 | <0.001* | <0.001** |
| Q3: During the past 6 months | 114 | 5.3 | 4.0 | <0.001* | 27 | 7.5 | 2.6 | <0.001* | <0.001** |
| Q3: Past week | 114 | 3.6 | 4.1 | 0.027* | 27 | 6.6 | 2.9 | 0.005* | <0.001** |
aMedian Mann–Whitney U test. bIR = Interquartile Range. cKruskal-Wallis p-value. *Significant result p<0.05 using Mann–Whitney U test.
**Significant result p<0.05 using Kruskal-Wallis test.
Figure 3Self-rated health before and during pregnancy and at Q2 and Q3.
Self-rated health
| 176 (100.0) | 34 (19.3) | 115 (65.3) | 27 (15.3) | | | | 24 | | |
| Very good | 62 (35.2) | 10 (29.4) | 43 (37.4) | 9 (33.3) | 0.056 | 0.052 | 0.284 | 9 (39.1) | 0.820 |
| Quite good | 92 (52.3) | 24 (70.6) | 56 (48.7) | 12 (44.4) | 11 (47.8) | ||||
| Fair | 15 (8.5) | - | 11 (9.6) | 4 (14.8) | 3 (13.0) | ||||
| Quite poor | 6 (3.4) | - | 5 (4.3) | 1 (3.7) | - | ||||
| Poor | 1 (0.6) | - | - | 1 (3.7) | - | ||||
| Very good | 25 (14.2) | 6 (17.6) | 17 (14.8) | 2 (7.4) | 0.961 | 0.099 | 0.041* | 3 (13.0) | 0.973 |
| Quite good | 54 (30.7) | 12 (35.3) | 37 (32.2) | 5 (18.5) | 8 (34.8) | ||||
| Fair | 57 (32.4) | 10 (29.4) | 38 (33.0) | 9 (33.3) | 8 (34.8) | ||||
| Quite poor | 27 (15.3) | 5 (14.7) | 17 (14.8) | 5 (18.5) | 3 (13.0) | ||||
| Poor | 13 (7.4) | 1 (2.9) | 6 (5.2) | 6 (22.2) | 1 (4.3) | ||||
| Very good | 31 (17.6) | 7 (20.6) | 22 (19.1) | 2 (7.4) | 0.726 | 0.223 | 0.050* | 6 (25.0) | 0.690 |
| Quite good | 82 (46.6) | 16 (47.1) | 55 (47.8) | 11 (40.7) | 9 (37.5) | ||||
| Fair | 48 (27.3) | 9 (26.5) | 31 (27.0) | 8 (29.6) | 7 (29.2) | ||||
| Quite poor | 9 (5.1) | 2 (5.9) | 3 (2.6) | 4 (14.8) | 2 (8.3) | ||||
| Poor | 6 (3.4) | - | 4 (3.5) | 2 (7.4) | - | | |||
| Very good | 27 (15.4) | 7 (20.6) | 18 (15.8) | 2 (7.4) | 0.538 | 0.166 | 0.132 | ||
| Quite good | 84 (48.0) | 18 (52.9) | 56 (49.1) | 10 (37.0) | |||||
| Fair | 50 (28.6) | 6 (17.6) | 34 (29.8) | 10 (37.0) | |||||
| Quite poor | 12 (6.9) | 3 (8.8) | 5 (4.4) | 4 (14.8) | |||||
| Poor | 2 (1.1) | 1 (0.9) | 1 (3.7) | ||||||
Test for difference between groups at Q3 (Pearson’s chi-square).
1‘No pain’ denotes respondents reporting remission of LBP/PGP at Q3.
2‘Recurrent pain’ denotes respondents reporting recurrent LBP/PGP at approximately 14 months after pregnancy at Q3.
3‘Continuous pain’ denotes respondents reporting continuous LBP/PGP at approximately 14 months after pregnancy at Q3.
4‘No pain’ vs. ‘Recurrent pain’, ‘No pain’ vs. ‘Continuous pain’ and Recurrent pain’ vs. ‘Continuous pain’.
5Non-respondents vs. respondents.
*Significance test p<0.05.
Relationship satisfaction
| 176 (100.0) | 34 (19.3) | 115 (65.3) | 27 (15.3) | | | | 24 | | |
| Very good | 137 (78.3) | 28 (82.4) | 88 (77.2) | 21 (77.8) | 0.784 | 0.905 | 0.860 | 12 (52.2) | 0.021* |
| Good | 29 (16.6) | 5 (14.7) | 19 (16.7) | 5 (18.5) | 10 (43.5) | ||||
| Neither good or bad | 6 (3.4) | 1 (2.9) | 4 (3.5) | 1 (3.7) | 1 (4.3) | ||||
| Bad | - | - | - | - | - | ||||
| Very bad | 3 (1.7) | - | 3 (2.6) | - | - | ||||
| Very good | 84 (48.3) | 15 (44.1) | 57 (50.4) | 12 (44.4) | 0.760 | 0.929 | 0.790 | 6 (25.0) | 0.164 |
| Good | 68 (39.1) | 15 (44.1) | 42 (37.2) | 11 (40.7) | 12 (50.0) | ||||
| Neither good or bad | 20 (11.5) | 4 (11.8) | 12 (10.6) | 4 (14.8) | 6 (25.0) | ||||
| Bad | - | - | - | - | - | ||||
| Very bad | 2 (1.1) | - | 2 (1.8) | - | - | ||||
| Very good | 84 (48.3) | 18 (52.9) | 53 (46.5) | 13 (50.0) | 0.819 | 0.714 | 0.557 | ||
| Good | 66 (37.9) | 11 (32.4) | 46 (40.4) | 9 (34.6) | |||||
| Neither good or bad | 16 (9.2) | 4 (11.8) | 9 (7.9) | 3 (11.5) | |||||
| Bad | 6 (3.4) | 1 (2.9) | 5 (4.4) | - | |||||
| Very bad | 2 (1.1) | - | 1 (0.9) | 1 (3.8) | |||||
Test for difference between groups at Q3 (Pearson’s chi-square).
1‘No pain’ denotes respondents reporting remission of LBP/PGP at Q3.
2‘Recurrent pain’ denotes respondents reporting recurrent LBP/PGP at approximately 14 months after pregnancy at Q3.
3‘Continuous pain’ denotes respondents reporting continuous LBP/PGP at approximately 14 months after pregnancy at Q3.
4‘No pain’ vs. ‘Recurrent pain’, ‘No pain’ vs. ‘Continuous pain’ and ‘Recurrent pain vs. ‘Continuous pain’.
5Non-respondents vs. respondents.
*Significance test p<0.05.